Two Novel Mutations (HBG1: c.-250C>T andHBG2: c.-250C>T) Associated With Hereditary Persistence of Fetal Hemoglobin

Genetic modifiers of  -thalassemia and clinical severity as assessed by age at first transfusion

(2012) F. Danjou et al.   HAEMATOLOGICA

Variants in genetic modifiers of  -thalassemia can help to predict the major or intermedia type of the disease

(2011) C. Badens et al.   HAEMATOLOGICA

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach

(2011) Belinda Giardine et al.   NATURE GENETICS

Amelioration of Sardinian  0 thalassemia by genetic modifiers

(2009) R. Galanello et al.   BLOOD

Control of fetal hemoglobin: new insights emerging from genomics and clinical implications

(2009) S. L. Thein et al.   HUMAN MOLECULAR GENETICS

BCL11A is a major HbF quantitative trait locus in three different populations with β-hemoglobinopathies

(2008) Amanda E. Sedgewick et al.   BLOOD CELLS MOLECULES AND DISEASES

DNA polymorphisms at the BCL11A, HBS1L-MYB, and  -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

(2008) G. Lettre et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gγ-196 C→T, Aγ-201 C→T: Two novel mutations in the promoter region of the γ-globin genes associated with nondeletional hereditary persistence of fetal hemoglobin in Greece

(2007) Magdalini Tasiopoulou et al.   BLOOD CELLS MOLECULES AND DISEASES